CD30/TNFRSF8 蛋白, Cynomolgus (HEK293, C-His)

CD30/TNFRSF8 protein (TNFSF8/CD30L receptor) is a key factor regulating cell growth and lymphoblast transformation and may activate NF-kappa-B signaling. CD30/TNFRSF8 Protein, Cynomolgus (HEK293, C-His) is the recombinant cynomolgus-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-His labeled tag. The total length of CD30/TNFRSF8 Protein, Cynomolgus (HEK293, C-His) is 368 a.a., with molecular weight of 75-105 kDa.

CD30/TNFRSF8 蛋白作为 TNFSF8/CD30L 的受体，在细胞生长的调节和活化的淋巴母细胞的转化中发挥着关键作用。此外，它可能通过激活 NF-kappa-B 信号传导参与基因表达的调节，从而促进多种细胞过程。

Immobilized Cynomolgus CD30, His Tag at 0.5 μg/mL (100μl/Well) on the plate. Dose response curve for Anti-CD30 Antibody, hFc Tag with the EC₅₀ of <7.2 ng/mL determined by ELISA.

Cynomolgus

HEK293

C-His

A0A2K5VW07 (A27-P394)

/

75-105 kDa

Greater than 95% as determined by reducing Tris-Bis PAGE.

无菌粉末.

Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. Normally 8% trehalose is added as protectant before lyophilization.

<1 EU/μg, determined by LAL method.

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH₂O.

Stored at -20°C for 2 years. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Room temperature in continental US; may vary elsewhere.